Fupin Hu
About
Fupin Hu is a scholar working on Molecular Medicine, Pharmacology and Epidemiology.
According to data from OpenAlex, Fupin Hu has authored 166 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Molecular Medicine, 61 papers in Pharmacology and 46 papers in Epidemiology. Recurrent topics in Fupin Hu's work include Antibiotic Resistance in Bacteria (133 papers), Antibiotics Pharmacokinetics and Efficacy (60 papers) and Bacterial Identification and Susceptibility Testing (37 papers). Fupin Hu is often cited by papers focused on Antibiotic Resistance in Bacteria (133 papers), Antibiotics Pharmacokinetics and Efficacy (60 papers) and Bacterial Identification and Susceptibility Testing (37 papers). Fupin Hu collaborates with scholars based in China, United States and United Kingdom. Fupin Hu's co-authors include Demei Zhu, Minggui Wang, Yan Guo, Shi Wu, Xiaogang Xu, Dandan Yin, Fu Wang, Renru Han, Qingyu Shi and Yonggui Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Advanced Materials.
In The Last Decade
Fupin Hu
162 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fupin Hu China | 35 | 2.8k | 1.1k | 939 | 931 | 905 | 166 | 4.4k | ||
| Patricia J. Simner United States | 38 | 3.3k 1.2× | 1.2k 1.1× | 1.2k 1.3× | 1.4k 1.5× | 879 1.0× | 147 | 5.2k | ||
| David W. Wareham United Kingdom | 38 | 2.9k 1.0× | 1.1k 1.0× | 1.1k 1.2× | 889 1.0× | 963 1.1× | 103 | 4.2k | ||
| Francesco Luzzaro Italy | 34 | 3.5k 1.2× | 826 0.8× | 1.5k 1.6× | 1.1k 1.2× | 939 1.0× | 112 | 4.3k | ||
| Ørjan Samuelsen Norway | 35 | 3.1k 1.1× | 765 0.7× | 1.4k 1.5× | 638 0.7× | 1.1k 1.2× | 95 | 4.0k | ||
| J. Kamile Rasheed United States | 34 | 3.3k 1.1× | 880 0.8× | 2.0k 2.1× | 903 1.0× | 1.1k 1.2× | 79 | 4.7k | ||
| Krystyna M. Kazmierczak United States | 43 | 3.0k 1.1× | 1.7k 1.6× | 776 0.8× | 1.3k 1.4× | 1.1k 1.3× | 72 | 4.8k | ||
| Lalitagauri M. Deshpande United States | 34 | 2.3k 0.8× | 954 0.9× | 774 0.8× | 898 1.0× | 914 1.0× | 95 | 3.9k | ||
| Hanna E. Sidjabat Australia | 38 | 3.2k 1.1× | 742 0.7× | 1.7k 1.8× | 1.0k 1.1× | 774 0.9× | 91 | 4.1k | ||
| Carl Urban United States | 32 | 3.0k 1.1× | 1.4k 1.3× | 1.1k 1.2× | 1.2k 1.3× | 650 0.7× | 94 | 4.2k | ||
| D. M. Livermore United Kingdom | 22 | 3.7k 1.3× | 1.2k 1.1× | 1.3k 1.4× | 1.0k 1.1× | 1.2k 1.4× | 25 | 4.8k |
Countries citing papers authored by Fupin Hu
Since
Specialization
Citations
This map shows the geographic impact of Fupin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fupin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fupin Hu more than expected).
Fields of papers citing papers by Fupin Hu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Fupin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fupin Hu. The network helps show where Fupin Hu may publish in the future.
Co-authorship network of co-authors of Fupin Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Fupin Hu. A scholar is included among the top collaborators of Fupin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fupin Hu. Fupin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Han, Renru, Chengkang Tang, Yu Feng, et al.. (2025). Extraintestinal pathogenic Escherichia coli (ExPEC) O-serotype distribution and antibiotic resistance profiles among the aging population in China: A longitudinal, multi-center study. International Journal of Antimicrobial Agents. 66(6). 107607–107607.
2.
Li, Ding, et al.. (2025). Molecular characterisation of two novel KPC variants mediating ceftazidime-avibactam resistance in ST11 Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 66(6). 107642–107642.
3.
Tang, Chengkang, et al.. (2024). Spread and evolution of blaKPC-plasmid between Serratia marcescens and Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 63(5). 107149–107149.
4.
Hu, Fupin, Yuqing Pan, Renru Han, et al.. (2024). Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study. Nature Microbiology. 9(3). 814–829.
5.
Shen, Siquan, Li Ding, Chengkang Tang, et al.. (2024). Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants. Journal of Clinical Microbiology. 62(7). e0015424–e0015424.
6.
Tang, Chengkang, Siquan Shen, Qingyu Shi, et al.. (2024). Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and blaKPC mutation. International Journal of Antimicrobial Agents. 64(2). 107228–107228.
7.
Tang, Chengkang, Siquan Shen, Qingyu Shi, et al.. (2024). Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance. International Journal of Antimicrobial Agents. 64(3). 107265–107265.
8.
Wang, Yue, Xiangning Huang, Siquan Shen, et al.. (2024). Modification of carbapenemase inhibition test and comparison of its performance with NG-Test CARBA 5 for detection of carbapenemase-producing Enterobacterales. Journal of Applied Microbiology. 135(8).
9.
Hu, Fupin, et al.. (2024). Performance of disk diffusion method for aztreonam in combination with avibactam against Enterobacteriales. Journal of Antimicrobial Chemotherapy. 79(6). 1309–1312.
10.
Zhuo, Chao, Wei Kang, Qiwen Yang, et al.. (2024). Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 79(9). 2246–2250.
11.
Yang, Shixin, Yao Wang, Yanjun Dong, et al.. (2024). Adaptive evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae in the urinary tract of a single patient. Proceedings of the National Academy of Sciences. 121(35). e2400446121–e2400446121.
12.
Zhang, Qin, Shi Wu, Li Ding, et al.. (2023). Antibiotic resistance and resistance mechanism of Corynebacterium kroppenstedtii isolated from patients with mastadenitis. European Journal of Clinical Microbiology & Infectious Diseases. 42(4). 525–528.
13.
Ren, Ning, Yujie Wu, Jie Qi, et al.. (2023). Tuning Ligands Ratio Allows for Controlling Gold Nanocluster Conformation and Activating a Nonantimicrobial Thiol Fragrance for Effective Treatment of MRSA‐Induced Keratitis. Advanced Materials. 35(40). e2303562–e2303562.
14.
Guo, Yan, Yang Yang, Renru Han, et al.. (2023). Multicenter Antimicrobial Resistance Surveillance of Clinical Isolates from Major Hospitals — China, 2022. China CDC Weekly. 5(52). 1155–1160.
15.
Kohira, Naoki, Meredith Hackel, Miki Takemura, et al.. (2022). In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020. Journal of Global Antimicrobial Resistance. 32. 181–186.
16.
Zhang, Z Y, et al.. (2020). Capsular polysaccharide and lipopolysaccharide O type analysis of Klebsiella pneumoniae isolates by genotype in China. Epidemiology and Infection. 148. e191–e191.
17.
Guo, Yan, Christi L. McElheny, Vaughn S. Cooper, et al.. (2017). High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium. Emerging infectious diseases. 23(11). 1902–1904.
18.
Liu, Yang, Chunhui Chen, Yan Guo, et al.. (2016). Characterization of Fosfomycin Resistance Gene, fosB, in Methicillin-Resistant Staphylococcus aureus Isolates. PLoS ONE. 11(5). e0154829–e0154829.
19.
Xu, Xiaogang, Chunhui Chen, Dongfang Lin, et al.. (2013). The Fosfomycin Resistance Gene fosB3 Is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus faecium Isolates. PLoS ONE. 8(10). e78106–e78106.
20.
Hu, Fupin, et al.. (2008). The molecular characteristics of E.coli and Klebsiella spp.with CLSI ESBL-screening test positive but cefepime-susceptible. Zhonghua jianyan yixue zazhi. 31(10). 1128–1133.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Patricia J. Simner Breakdown of academic impact, for papers by David W. Wareham Breakdown of academic impact, for papers by Francesco Luzzaro Breakdown of academic impact, for papers by Ørjan Samuelsen Breakdown of academic impact, for papers by J. Kamile Rasheed Breakdown of academic impact, for papers by Krystyna M. Kazmierczak Breakdown of academic impact, for papers by Lalitagauri M. Deshpande Breakdown of academic impact, for papers by Hanna E. Sidjabat Breakdown of academic impact, for papers by Carl Urban Breakdown of academic impact, for papers by D. M. Livermore